Risk of Heart Inflammation from mRNA Vaccines

Heart inflammation primarily presents in three forms: myocarditis (inflammation of the heart muscle), pericarditis (inflammation of the outer lining of the heart), and endocarditis (inflammation of the inner lining of the heart). However, only myocarditis and pericarditis have been linked to mRNA vaccines.

Common indicators of myocarditis and pericarditis following mRNA vaccination include elevated troponin levels (a biomarker for heart muscle damage), abnormal cardiac imaging results, and chest pain. Less common symptoms may also include headaches, shortness of breath, fatigue, and general body aches.

In my previous article, "mRNA Vaccine Safety and Risks: A One-Year Update From the U.S., U.K., and Israel," I summarized findings from two significant studies regarding heart inflammation risks. Here’s a brief overview of their results:

One study from Israel indicated that individuals receiving the Pfizer mRNA vaccine had a 3.24-fold increased risk of myocarditis within 21 days of receiving either their first or second dose, compared to those who were unvaccinated. This translated to an additional 2.7 cases per 100,000 individuals, with about 90% of cases occurring in males aged 20-34.

The second study conducted in the U.S. revealed that individuals aged 12-39 had a 9.8-fold increased risk of myocarditis/pericarditis within 21 days post-vaccination compared to those vaccinated later. This represented an additional 6.3 cases per million doses. Notably, 85% of cases involved males, with 82% leading to hospitalization. Thankfully, no fatalities were reported.

These studies underscore that mRNA vaccine-related heart inflammation primarily affects younger males, typically within a week of the first or, more often, the second dose.

Probable Causes of Heart Inflammation

Infections are unlikely to be the root cause of myocarditis or pericarditis in newly vaccinated individuals. Several case studies have failed to identify infections that typically cause heart inflammation in those recently vaccinated.

An animal study published recently provides insights into potential causes of heart inflammation linked to mRNA vaccines. Researchers examined the blood and tissue profiles of mice vaccinated with Pfizer's mRNA vaccine through intramuscular versus intravenous routes. The intravenous route resulted in apoptotic cell death in heart muscle cells, suggesting a connection to myocarditis. However, these mice showed no clinical symptoms of illness.

Interestingly, myocarditis or spike protein expression was absent in the intramuscular group. The authors speculate that accidental intravenous injection during intramuscular administration could trigger myocarditis and pericarditis in humans.

An editorial accompanying the study noted, "The rare injection of a vaccine into a vein during planned intramuscular injection could contribute to the onset of myopericarditis." Aspiration, or drawing back the syringe plunger before injection, is a controversial practice with limited benefits, as large blood vessels are uncommon in the deltoid muscle.

The CDC and WHO currently do not recommend aspiration before administering vaccines to minimize patient discomfort. However, with the mass vaccination efforts during the COVID-19 pandemic, there may be overlooked risks associated with this practice. Further research is warranted to determine the safest injection techniques.

If traces of the mRNA vaccine were to enter the bloodstream, they might theoretically reach the T-tubules of heart muscle cells, allowing for potential inflammation.

Another hypothesis suggests that antibodies formed in response to the mRNA vaccine may mistakenly target heart proteins due to structural similarities, particularly in individuals predisposed to autoimmune disorders.

Lastly, younger males may metabolize the mRNA vaccine more quickly, potentially leading to increased spike protein production, resulting in heightened inflammation.

Recent insights indicate that Moderna's mRNA vaccine might present a 2.5-fold greater risk of myocarditis compared to Pfizer's vaccine, likely due to its higher dosage.

Risk-Benefit Analysis of mRNA Vaccines

Does this imply that younger males should switch to alternative COVID-19 vaccines? Not necessarily. Currently, the benefits of mRNA vaccines still surpass the associated risk of heart inflammation. However, the situation may differ for booster doses.

Firstly, the occurrence of mRNA vaccine-related heart inflammation remains very rare—2.7 cases per 100,000 individuals or 6.3 cases per million doses, according to the studies mentioned earlier.

Secondly, despite hundreds of cases of heart inflammation in young adults, no deaths have been linked to these incidents, aside from isolated reports that raise questions about causation.

Thirdly, while mRNA vaccine-related heart inflammation can be serious enough to require hospitalization, it typically resolves swiftly with standard anti-inflammatory treatment. The long-term effects of this condition are still uncertain, as is the case for long-COVID syndrome.

Fourthly, mRNA vaccines are among the most effective COVID-19 vaccines available, providing substantial protection against SARS-CoV-2, which carries a much higher risk of causing heart inflammation.

Lastly, mRNA vaccines have undergone extensive research, with Pfizer's vaccine being the first to receive FDA approval. The identification of heart inflammation related to mRNA vaccines further highlights their rigorous safety evaluations.

Thus, the benefits of mRNA vaccination appear to outweigh the risks. If they didn't, many countries would have restricted their use in younger populations, as seen with the AstraZeneca vaccine in certain demographics.

The CDC's Advisory Committee on Immunization Practices (ACIP) conducted a comprehensive analysis of the risks and benefits of mRNA vaccines. Although long-COVID was not included in their analysis, they concluded that the advantages of mRNA vaccines still outweigh the risks across all examined age and sex categories.

In the case of booster shots, the risk-benefit balance becomes more complex. Since the second dose elicits a stronger immune response, the third dose may similarly increase the risk of heart inflammation.

Utilizing a different COVID-19 vaccine for the third shot could yield a more balanced immune response, but this topic requires further research. The FDA recently voted against recommending boosters for individuals under 65, indicating that more investigation is necessary.

Precautions to Consider

The CDC advises individuals who have experienced myocarditis or pericarditis following an mRNA vaccine dose to refrain from receiving subsequent doses. Nonetheless, depending on individual circumstances, a follow-up dose may still be advised if the heart condition has fully resolved.

While the CDC acknowledges limited data on the vaccination of individuals with a history of heart inflammation, they recommend vaccination for those whose condition has completely healed. However, both the CDC and the Australian government do not recommend mRNA vaccines for those with ongoing heart inflammation.

In Hong Kong, only one dose of Pfizer’s mRNA vaccine is recommended for children aged 12-17 to mitigate heart inflammation risks. The U.K. and Norway have taken similar approaches, administering one dose initially and postponing decisions on the second dose.

Singapore's health minister advises against strenuous exercise for two weeks following vaccination, particularly for males under 30, based on observations that intense physical activity may trigger heart inflammation.

Lastly, it may also be beneficial to allow adequate rest after vaccination to support the immune response without inducing additional inflammation. Lifestyle factors, such as diet, sleep, and stress, can contribute to inflammatory responses in the body.

Thank you for reading. If you found this information helpful, consider subscribing to my Medium email list. For those interested in unlimited access to Medium, feel free to use my referral link, which provides me with a small commission at no extra cost to you. Your support is greatly appreciated as I navigate the challenges of science writing.

Heart inflammation as a COVID-19 vaccine side effect - YouTube

This video explores the relationship between heart inflammation and mRNA vaccines, detailing the potential risks and research findings.

CDC investigates possible connection between mRNA vaccine, heart inflammation

This video discusses the CDC's investigation into heart inflammation cases associated with mRNA vaccines and what it could mean for public health.